Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Jump-Start Your Search For Promising Trade Ideas With Barchart Premier’s "Top Stock Pick". FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Abbvie Inc (ABBV)

Abbvie Inc (ABBV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 284,737,728
  • Shares Outstanding, K 1,770,647
  • Annual Sales, $ 54,318 M
  • Annual Income, $ 4,863 M
  • 60-Month Beta 0.61
  • Price/Sales 5.27
  • Price/Cash Flow 10.28
  • Price/Book 28.16
Trade ABBV with:

Options Overview Details

View History
  • Implied Volatility 18.05% ( -0.68%)
  • Historical Volatility 25.96%
  • IV Percentile 26%
  • IV Rank 17.79%
  • IV High 29.42% on 04/12/24
  • IV Low 15.58% on 09/01/23
  • Put/Call Vol Ratio 0.80
  • Today's Volume 20,041
  • Volume Avg (30-Day) 29,232
  • Put/Call OI Ratio 0.81
  • Today's Open Interest 363,262
  • Open Int (30-Day) 355,859

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 21 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/24
See More
  • Average Estimate 3.06
  • Number of Estimates 9
  • High Estimate 3.11
  • Low Estimate 3.00
  • Prior Year 2.91
  • Growth Rate Est. (year over year) +5.15%

Price Performance

See More
Period Period Low Period High Performance
1-Month
157.65 +3.99%
on 04/26/24
177.70 -7.74%
on 04/04/24
-13.38 (-7.55%)
since 04/03/24
3-Month
157.65 +3.99%
on 04/26/24
182.89 -10.36%
on 03/12/24
-4.72 (-2.80%)
since 02/02/24
52-Week
130.96 +25.19%
on 06/28/23
182.89 -10.36%
on 03/12/24
+14.70 (+9.85%)
since 05/03/23

Most Recent Stories

More News
U.S. Representative Michael C. Burgess Just Reported a Sale of $ABBV stock

In a new disclosure filed today, U.S. Representative Michael C. Burgess reported the sale of $1,001 - $15,000 of ABBVIE INC. COMMON STOCK, in a trade that took place on April 10. Since that trade was made,...

ABBV : 163.79 (+1.85%)
Better Dividend Stock: AbbVie or Johnson & Johnson?

One thing is for sure: Dividend seekers can't go wrong with either.

ABT : 105.90 (-0.02%)
ABBV : 163.79 (+1.85%)
JNJ : 149.27 (-0.43%)
3 Dividend Stocks to Buy and Hold for the Next Decade

You'll get dividends and more with these great stocks.

ABT : 105.90 (-0.02%)
ABBV : 163.79 (+1.85%)
LLY : 734.97 (-2.77%)
PFE : 27.81 (+0.40%)
Why AbbVie Stock Stumbled Today Despite the Earnings Beat

Investors are struggling to see past the end of Humira's dominance.

ABBV : 163.79 (+1.85%)
AbbVie (ABBV) Q1 2024 Earnings Call Transcript

ABBV earnings call for the period ending March 31, 2024.

ABBV : 163.79 (+1.85%)
AbbVie: Q1 Earnings Snapshot

AbbVie: Q1 Earnings Snapshot

ABBV : 163.79 (+1.85%)
Stock Index Futures Climb on Upbeat Big Tech Earnings, U.S. Inflation Data Looms

June S&P 500 E-Mini futures (ESM24) are up +0.63%, and June Nasdaq 100 E-Mini futures (NQM24) are up +0.86% this morning as upbeat quarterly results from tech titans Alphabet and Microsoft boosted sentiment,...

ESM24 : 5,161.50 (+1.37%)
NQM24 : 18,023.00 (+2.11%)
GOOGL : 167.24 (+0.37%)
MSFT : 406.66 (+2.22%)
META : 451.96 (+2.33%)
TXT : 85.59 (+0.26%)
IBM : 165.71 (+0.62%)
NEM : 40.66 (-0.95%)
XOM : 116.00 (-0.21%)
ABBV : 163.79 (+1.85%)
CVX : 160.25 (-0.30%)
CL : 92.88 (-0.03%)
Buying the Dip in These 3 Undervalued Dividend Stocks

All three of these stocks look intriguing.

MCD : 270.32 (-1.08%)
COP : 122.23 (-0.02%)
ABBV : 163.79 (+1.85%)
Stocks Set to Open Higher as Investors Await Key U.S. Inflation Data and Big Tech Earnings

June S&P 500 E-Mini futures (ESM24) are up +0.48%, and June Nasdaq 100 E-Mini futures (NQM24) are up +0.58% this morning as market participants looked ahead to earnings reports from some of the biggest...

ESM24 : 5,161.50 (+1.37%)
NQM24 : 18,023.00 (+2.11%)
NFLX : 579.34 (+2.51%)
AMD : 150.60 (+3.04%)
MU : 114.70 (+2.11%)
ULTA : 397.39 (+0.02%)
PARA : 12.89 (-7.00%)
AXP : 230.77 (-0.74%)
TSLA : 181.19 (+0.66%)
META : 451.96 (+2.33%)
MSFT : 406.66 (+2.22%)
GOOGL : 167.24 (+0.37%)
Why I Keep Buying This Ultra-High-Yielding ETF for Passive Income

The JPMorgan Equity Premium Income ETF produces a lucrative monthly passive income stream.

JPM : 190.51 (-0.60%)
XOM : 116.00 (-0.21%)
PGR : 208.72 (-0.15%)
ABBV : 163.79 (+1.85%)
TT : 319.29 (+0.79%)
META : 451.96 (+2.33%)
MSFT : 406.66 (+2.22%)
AMZN : 186.21 (+0.81%)
JEPI : 56.06 (+0.66%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 8% Buy with a Weakest short term outlook on maintaining the current direction.

See More Share

Business Summary

AbbVie has become one of the top-most pharma companies after it acquired Allergan. The deal has transformed AbbVie's portfolio by lowering its dependence on Humira, its flagship product. AbbVie has one of the most popular cancer drugs in its portfolio, Imbruvica and its newest immunology drugs Skyrizi...

See More

Key Turning Points

3rd Resistance Point 167.11
2nd Resistance Point 164.78
1st Resistance Point 162.79
Last Price 163.79
1st Support Level 158.47
2nd Support Level 156.14
3rd Support Level 154.15

See More

52-Week High 182.89
Last Price 163.79
Fibonacci 61.8% 163.05
Fibonacci 50% 156.93
Fibonacci 38.2% 150.80
52-Week Low 130.96

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar